98%
921
2 minutes
20
Background: Dietary fiber supports metabolic health via microbial fermentation, producing short-chain fatty acids (SCFAs). However, metabolic responses to fiber vary between individuals, potentially due to differences in gut microbiota composition. The Prevotella-to-Bacteroides (P/B) ratio has emerged as a potential biomarker for fiber responsiveness.
Objective: This study examined how stratified fiber supplementation affects microbial and metabolic outcomes in individuals with Prevotella- or Bacteroides-dominated microbiota.
Methods: In this single-blinded, randomized cross-over study, 23 healthy adults were classified as P-type (≥10% Prevotella) or B-type (≥10% Bacteroides) via 16S rRNA sequencing. Participants consumed 15 g/day of arabinoxylan (AX), inulin (INU), or placebo (PLA) for one week each, with 2-week washouts. After each phase, fasting and postprandial plasma SCFAs, branched-chain fatty acids (BCFAs), breath hydrogen, glucose, insulin, PYY, cholesterol, appetite ratings, and fecal microbiota were assessed. Data were analyzed using repeated measures ANOVA, Friedman test, and multivariate microbiome analysis.
Results: In P-types, AX increased fasting propionate vs. PLA (p = 0.04). In B-types, AX increased fasting propionate vs. INU (p = 0.02) and tended to elevate postprandial propionate vs. PLA in the first 60 minutes after breakfast (p = 0.05). AX also increased postprandial acetate vs. PLA in B-types (p = 0.04). INU reduced fasting BCFAs in B-types (p < 0.05) but did not increase SCFAs. Breath hydrogen varied widely in B-types after INU but not in P-types. Neither fiber affected glucose, insulin, or PYY. AX reduced appetite ratings in P-types (p < 0.05). INU increased Anaerostipes and Bifidobacterium and reduced Phocaeicola in both groups (q < 0.25). AX increased Fusicatenibacter in B-types (q = 0.18) and Paraprevotella in P-types (q = 0.17).
Conclusions: B-types exhibited fiber-specific shifts in SCFA and BCFA metabolism and breath hydrogen, whereas P-types displayed a more limited overall response, with fewer metabolic and microbial parameter affected. These findings highlight the complexity of diet-microbiota interactions and support the potential relevance for microbiota-based nutrition strategies. German Register of Clinical Studies (DRKS00028898).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.tjnut.2025.08.034 | DOI Listing |
Front Nutr
August 2025
Department of Food Science and Human Nutrition, University of Veterinary and Animal Sciences, Lahore, Pakistan.
Introduction: Olive leaf has strong antibacterial and anti-inflammatory properties, potentially modulating gut microbiota composition. This may help address small intestinal bacterial overgrowth (SIBO), a gastrointestinal (GI) problem causing malabsorption and potential complications.
Objective: This study aimed to observe the effect of olive leaf tea (OLT) on GI symptoms, body composition, and the hydrogen/methane breath test among patients suffering from SIBO.
J Nutr
September 2025
Institute of Food and One Health, Leibniz University Hannover, 30167 Hannover, Germany.
Background: Dietary fiber supports metabolic health via microbial fermentation, producing short-chain fatty acids (SCFAs). However, metabolic responses to fiber vary between individuals, potentially due to differences in gut microbiota composition. The Prevotella-to-Bacteroides (P/B) ratio has emerged as a potential biomarker for fiber responsiveness.
View Article and Find Full Text PDFDig Dis Sci
September 2025
Department of Gastroenterology & Hepatology, Singapore General Hospital, Singapore, Singapore.
Helicobacter
September 2025
Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Background: The optimal duration for vonoprazan and amoxicillin dual therapy (VA-DT) remains unclear, and studies on gastric acid suppression of vonoprazan during eradication are still lacking.
Objective: This study conducted a multicenter, randomized controlled trial to compare the eradication efficacy between 10 and 14-day VA-DT, and to identify the dynamic changes of gastric pH during treatment.
Methods: This study included 418 naïve adult patients with Helicobacter pylori infection, who were randomly divided into 10 or 14-day VA-DT groups (vonoprazan 20 mg twice daily and amoxicillin 1000 mg thrice daily).
Redox Biol
August 2025
Institute of Pharmaceutical Science, King's College London, London, UK; Bloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, London, UK; Centre for Pharmaceutical Medicine Research, King's College London, London, UK. Electronic address:
Redox-active, copper-chelating thiomolybdates are a family of metal-based therapeutics used to treat copper toxicity in animals and Wilson's disease in humans, and studied in other indications including cancer, inflammatory and fibrotic conditions. Thiomolybdates act through multiple mechanisms including copper chelation, redox regulation (e.g.
View Article and Find Full Text PDF